Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.

Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, Ganta S, Adamo R, Amiji M, Friedman G, Levy RJ.

Proc Natl Acad Sci U S A. 2010 May 4;107(18):8346-51. doi: 10.1073/pnas.0909506107. Epub 2010 Apr 19.

2.

Drug-eluting stents.

García-García HM, Vaina S, Tsuchida K, Serruys PW.

Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.

PMID:
17091802
3.

Paclitaxel-eluting stents: current clinical experience.

Grube E, Buellesfeld L.

Am J Cardiovasc Drugs. 2004;4(6):355-60. Review.

PMID:
15554720
4.

Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.

Chorny M, Fishbein I, Adamo RF, Forbes SP, Folchman-Wagner Z, Alferiev IS.

Methodist Debakey Cardiovasc J. 2012 Jan;8(1):23-7. Review.

5.

Initial experience with paclitaxel-coated stents.

Grube E, Büllesfeld L.

J Interv Cardiol. 2002 Dec;15(6):471-5. Review.

PMID:
12476650
6.

[Drug-eluting stents do they make the difference? ].

Presbitero P, Asioli M.

Minerva Cardioangiol. 2002 Oct;50(5):431-42. Review. Italian.

PMID:
12384625
7.

Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.

Ahmed WH.

Expert Rev Med Devices. 2007 Mar;4(2):117-20. Review.

PMID:
17359218
8.
9.

Paclitaxel-eluting stents in coronary artery disease.

Nawarskas JJ, Osborn LA.

Am J Health Syst Pharm. 2005 Nov 1;62(21):2241-51. Review.

PMID:
16239414
10.

Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?

Antoniou GA, Georgakarakos EI, Antoniou SA, Georgiadis GS.

Interact Cardiovasc Thorac Surg. 2014 Aug;19(2):282-5. doi: 10.1093/icvts/ivu093. Epub 2014 Apr 11. Review.

PMID:
24729201
11.

Perspectives of drug-eluting stents: the next revolution.

Moses JW, Kipshidze N, Leon MB.

Am J Cardiovasc Drugs. 2002;2(3):163-72. Review.

PMID:
14727979
12.

Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, Kaiser C, D'Ascenzo F, Frati G, Mancone M, Genereux P, Stone GW.

J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6. Review.

14.

Drug-eluting stent: the emerging technique for the prevention of restenosis.

Sheiban I, Carrieri L, Catuzzo B, Destefanis P, Oliaro E, Moretti C, Trevi GP.

Minerva Cardioangiol. 2002 Oct;50(5):443-53. Review.

PMID:
12384626
15.

Magnetic nanoparticles for targeted vascular delivery.

Chorny M, Fishbein I, Forbes S, Alferiev I.

IUBMB Life. 2011 Aug;63(8):613-20. doi: 10.1002/iub.479. Epub 2011 Jun 30. Review.

16.

Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

Veiseh O, Gunn JW, Zhang M.

Adv Drug Deliv Rev. 2010 Mar 8;62(3):284-304. doi: 10.1016/j.addr.2009.11.002. Epub 2009 Nov 10. Review.

17.

Potential of magnetic nanoparticles for targeted drug delivery.

Yang HW, Hua MY, Liu HL, Huang CY, Wei KC.

Nanotechnol Sci Appl. 2012 Aug 27;5:73-86. doi: 10.2147/NSA.S35506. Review.

18.

Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Takahashi H, Letourneur D, Grainger DW.

Biomacromolecules. 2007 Nov;8(11):3281-93. Epub 2007 Oct 12. Review.

19.

Magnetic nanoparticles and nanocomposites for remote controlled therapies.

Hauser AK, Wydra RJ, Stocke NA, Anderson KW, Hilt JZ.

J Control Release. 2015 Dec 10;219:76-94. doi: 10.1016/j.jconrel.2015.09.039. Epub 2015 Sep 25. Review.

Supplemental Content

Support Center